A Real-world Study of Indian Patients With Advanced Breast Cancer Treated With Ribociclib
Clinical trial NCT07363434 · COMPLETED
Trial details
- NCT number
- NCT07363434
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-21
- Primary completion
- 2024-07-26
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.